OpenFilings

Ultragenyx Pharmaceutical Inc.

Form10-K

Report Period2024-12-31

Date Filed2025-02-19

Time Filed16:58:50

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-10.15
EX-10.16
EX-10.38
EX-10.77
EX-10.84
EX-10.89
EX-10.93
EX-19.1
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
Filing on SEC Edgar